研究用フローサイトと理化学分析

世界のリサーチ分野のお客さまへ先端の検査装置のご案内です。

お問い合わせはこちら

sysmex

研究用フローサイトと理化学分析sysmex

CyFlow HLA-G FITC

品番 CB784162
抗体名 Anti-Hu HLA-G FITC,01G
包装単位 0.1 mg
濃度 1 mg/ml
容量 0.1 ml
関連製品
(アイソタイプコントロール)
Mouse IgG1 FITC (CD051682)
反応性|交差吸着 Human レーザー Blue
抗原 HLA-G 最大蛍光波長 518 nm
クローン 01G 最大励起波長 490 to 495 nm
ホスト Mouse 標識/Format FITC
アイソタイプ IgG1 研究分野 MHC
クローナリティ monoclonal 用途

Flow cytometry

Anti-Hu HLA-G FITC,01G

特異性

The mouse monoclonal antibody 01G recognizes membrane-bound form of HLA-G (full-length HLA-G1) antigen, but not soluble forms. HLA-G belongs to the MHC Class I molecules (MHC Class Ib; nonclassical) and it is expressed on the surface of trophoblast cells.

抗原情報

利用方法

The reagent is designed for Flow Cytometry analysis. Suggested working usage is 5 µg/ml. Indicated dilution is recommended starting point for use of this product, but working concentrations should be validated by the investigator.

保存方法

Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.

安定性情報

Do not use after expiration date stamped on vial label.

レファレンス

• Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE: Protein Expression and Peptide Binding Suggest Unique and Interacting Functional Roles for HLA‑E, F and G in Maternal‑Placental Immune Recognitions. J·Immunol. 2003; 171:1376. <·PMID:·12874228·>
• Polakova K, Bandzuchova E, Hofmeister V, Weiss EH, Hutter H, Russ G: Binding analysis of HLA‑G specific antibodies to hematopoietic cells isolated from leukemia patients. Neoplasma. 2003; 50(5):331‑8. <·PMID:·14628085·>
• Polakova K, Krcova M, Kuba D, Russ G: Analysis of HLA‑G expression in malignant hematopoetic cells from leukemia patients. Leuk·Res. 2003·Jul; 27(7):643‑8. <·PMID:·12681364·>
• Polakova K, Russ G: Expression of the non‑classical HLA‑G antigen in tumor cell lines is extremely restricted. Neoplasma. 2000; 47(6):342‑8. <·PMID:·11263857·>
• Real LM, Cabrera T, Canton J, Oliva R, Ruiz-Cabello F, Garrido F: Looking for HLA‑G expression in human tumours. J·Reprod·Immunol. 1999·Jul; 43(2):263‑73. <·PMID:·10479062·>
• Real LM, Cabrera T, Collado A, Jimenez P, Garcia A, Ruiz-Cabello F, Garrido F: Expression of HLA G in human tumors is not a frequent event. Int·J·Cancer. 1999·May·17; 81(4):512‑8. <·PMID:·10225437·>
• Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M: Expression of the immune‑tolerogenic major histocompatibility molecule HLA‑G in multiple sclerosis: implications for CNS immunity. Brain. 2005·Nov; 128(11):2689‑2704. <·PMID:·16123145·>

Available Safety Data Sheets

CyFlow™ monoclonal antibodies SDS CA EN

Available Technical Data Sheets

CyFlow™ HLA-G FITC (01G) CB784162 TDS (US)